Cargando…

Antiepileptogenesis and disease modification: Clinical and regulatory issues

This is a summary report of clinical and regulatory issues discussed at the 2018 NINDS workshop, entitled “Accelerating Therapies for Antiepileptogenesis and Disease Modification.” The intent of the workshop was to optimize and accelerate development of therapies for antiepileptogenesis (AEG) and di...

Descripción completa

Detalles Bibliográficos
Autores principales:	French, Jacqueline A., Bebin, Martina, Dichter, Marc A., Engel, Jerome, Hartman, Adam L., Jóźwiak, Sergiusz, Klein, Pavel, McNamara, James, Twyman, Roy, Vespa, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Special Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408600/ https://www.ncbi.nlm.nih.gov/pubmed/34270884 http://dx.doi.org/10.1002/epi4.12526

Ejemplares similares

Antiepileptogenesis and disease modification: Progress, challenges, and the path forward—Report of the Preclinical Working Group of the 2018 NINDS‐sponsored antiepileptogenesis and disease modification workshop
por: Galanopoulou, Aristea S., et al.
Publicado: (2021)

Selected Molecular Targets for Antiepileptogenesis
por: Pawlik, Marek J., et al.
Publicado: (2021)

Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital
por: Barker‐Haliski, Melissa, et al.
Publicado: (2021)

Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate
por: Koepp, Matthias J., et al.
Publicado: (2023)

Editorial: Tuberous Sclerosis Complex – Diagnosis and Management
por: Jozwiak, Sergiusz, et al.
Publicado: (2021)

Prediction of rapid maxillary expansion by assessing the maturation of the midpalatal suture on cone beam CT
por: Angelieri, Fernanda, et al.
Publicado: (2016)

Novel study design to assess the efficacy and tolerability of antiseizure medications for focal‐onset seizures in infants and young children: A consensus document from the regulatory task force and the pediatric commission of the International League against Epilepsy (ILAE), in collaboration with the Pediatric Epilepsy Research Consortium (PERC)
por: Auvin, Stéphane, et al.
Publicado: (2019)

Risk Factors Associated with Refractory Epilepsy in Patients with Tuberous Sclerosis Complex: A Systematic Review
por: Miszewska, Dominika, et al.
Publicado: (2021)

Safety of Sirolimus in Patients with Tuberous Sclerosis Complex under Two Years of Age—A Bicenter Retrospective Study
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Regulatory functions of B cells and regulatory plasma cells
por: Fillatreau, Simon
Publicado: (2019)

On covert medication: The issues involved
por: Sarin, Alok
Publicado: (2012)

Childhood Obesity: Issues of Weight Bias
por: Washington, Reginald L.
Publicado: (2011)

Emerging issues in peripheral nerve repair☆
por: Geuna, Stefano, et al.
Publicado: (2012)

Statistical issues in trials of preexposure prophylaxis
por: Dunn, David T., et al.
Publicado: (2016)

Ethical Issues in Contemporary Clinical Genetics
por: Braverman, Genna, et al.
Publicado: (2018)

Current ethical issues for African psychiatry
por: Zabow, Tuviah
Publicado: (2004)

A case of symmetric retrograde thromboembolic cerebral infarction in an 8-year-old child due to arterial thoracic outlet syndrome
por: Strzelecka, Jolanta, et al.
Publicado: (2018)

Treatment of Cardiac Rhabdomyomas with mTOR Inhibitors in Children with Tuberous Sclerosis Complex—A Systematic Review
por: Sugalska, Monika, et al.
Publicado: (2021)

Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age
por: Śmiałek, Dominika, et al.
Publicado: (2023)

How common are sleep issues and burnout in Irish farmers?
por: Firnhaber, J, et al.
Publicado: (2023)

Medico-legal and ethical issues in anaesthesiology profession
por: Shinde, Surekha S, et al.
Publicado: (2021)

Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study
por: Franz, David N., et al.
Publicado: (2016)

Postmarket Modifications of High-risk Plastic Surgery Devices
por: Olaiya, Oluwatobi R., et al.
Publicado: (2020)

Reframing School Dropout as a Public Health Issue
por: Freudenberg, Nicholas, et al.
Publicado: (2007)

JBMRPlus: Special Issue on Rare Bone Diseases 2019
por: Shore, Eileen M., et al.
Publicado: (2019)

AI Implementation Science for Social Issues: Pitfalls and Tips
por: Takaoka, Kota
Publicado: (2022)

Augmented Reality in Stereotactic Neurosurgery: Current Status and Issues
por: SATOH, Makoto, et al.
Publicado: (2023)

COVID‐19 modifications to a first year medical human anatomy course: Effects on student performance on summative examinations
por: McNamara, John Patrick, et al.
Publicado: (2022)

The importance of social identities in the management of and recovery from ‘Diabulimia’: A qualitative exploration
por: Hastings, Amy, et al.
Publicado: (2016)

Introduction to Special Issue
por: Honavar, Santosh G
Publicado: (2012)

Environmental Health Research Involving Human Subjects: Ethical Issues
por: Resnik, David B.
Publicado: (2008)

Prospective payment for Medicare skilled nursing facilities: Background and issues
por: Schieber, George, et al.
Publicado: (1986)

Medigap preferred provider organizations: Issues, implications, and early experience
por: Nelson, Lyle, et al.
Publicado: (1991)

Legal Issues in Quarantine and Isolation for Control of Emerging Infectious Diseases
por: Kim, Cheonsoo
Publicado: (2016)

Exploring ways to manage healthcare professional—patient communication issues
por: Leonard, Pauline
Publicado: (2017)

Face masks in the general healthy population. Scientific and ethical issues
por: Royo-Bordonada, Miguel Angel, et al.
Publicado: (2021)

Regulatory issues in Europe
por: Madsen, Charlotte B
Publicado: (2011)

Editorial: Viral vector-based gene therapy in neurological disease: The future is now
por: Smith, Jared B., et al.
Publicado: (2023)

Zebrafish regulatory genomic resources for disease modelling and regeneration
por: Jimenez Gonzalez, Ada, et al.
Publicado: (2023)

ReGARDD (Regulatory Guidance for Academic Research of Drugs and Devices): The evolution of a collaborative regional CTSA-funded forum and website for regulatory support
por: Brownley, Kimberly A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9guntbtn1d89neg21kch5gl4jm